Upregulation of HYAL1 expression in breast cancer promoted tumor cell proliferation, migration, invasion and angiogenesis

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Tan, Jin Xiang ^a   Wang, Xiao Yi ^a   Su, Xin Liang ^a   Li, Hong Yuan ^a   Shi, Yuan ^b   Wang, Liang ^c   Ren, Guo Sheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c First People's Hospital of Jiulongpo District   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSIDASE; HYALURONIC ACID; HYALURONIDASE 1; UNCLASSIFIED DRUG; HYALURONOGLUCOSAMINIDASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL; TUMOR VASCULARIZATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL STRAIN 3T3; CYTOLOGY; ENZYME IMMUNOASSAY; FLOW CYTOMETRY; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; WESTERN BLOTTING; WOUND HEALING;

MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HUMANS; HYALURONOGLUCOSAMINIDASE; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UMBILICAL VEINS; UP-REGULATION; WOUND HEALING;

EID: 79960855619     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022836     Document Type: Article

References (41)

1. Simpson MA, Lokeshwar VB, (2008) Hyaluronan and hyaluronidase in genitourinary tumors. Front Biosci 13: 5664-5680.
2. Laurent TC, Fraser JR, (1992) Hyaluronan. FASEB J 6: 2397-2404.
3. Tammi MI, Day AJ, Turley EA, (2002) Hyaluronan and homeostasis: a balancing act. J Biol Chem 277: 4581-4584.
4. Turley EA, Noble PW, Bourguignon LY, (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277: 4589-4592.
5. Toole BP, Wight TN, Tammi MI, (2002) Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277: 4593-4596.
6. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, et al. (1998) Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342-347.
7. Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, et al. (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156: 529-536.
8. Pirinen R, Tammi R, Tammi M, Hirvikoski P, Parkkinen JJ, et al. (2001) Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. Int J Cancer 95: 12-17.
9. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, et al. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276: 11922-11932.
10. Lokeshwar VB, Obek C, Pham HT, Wei D, Young MJ, et al. (2000) Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J Urol 163: 348-356.
11. Slevin M, Krupinski J, Kumar S, Gaffney J, (1998) Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 78: 987-1003.
12. Rooney P, Kumar S, Ponting J, Wang M, (1995) The role of hyaluronan in tumour neovascularization. Int J Cancer 60: 632-636.
13. Hayen W, Goebeler M, Kumar S, Riessen R, Nehls V, (1999) Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 112: 2241-2251.
14. Tanabe KK, Nishi T, Saya H, (1993) Novel variants of CD44 arising from alternative splicing: changes in the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells treated with hyaluronidase. Mol Carcinog 7: 212-220.
15. Lin G, Stern R, (2001) Plasma hyaluronidase (Hyal-1) promotes tumor cell cycling. Cancer Lett 163: 95-101.
16. Frost GI, Csóka AB, Wong T, Stern R, (1997) Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun 236: 10-15.
17. Csóka AB, Frost GI, Wong T, Stern R, (1997) Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett 417: 307-310.
18. Bertrand P, Girard N, Duval C, d'Anjou J, Chauzy C, et al. (1997) Increased hyaluronidase levels in breast tumor metastases. Int J Cancer 73: 327-331.
19. Tan JX, Wang XY, Li HY, Su XL, Wang L, et al. (2011) HYAL1 overexpression is correlated with the malignant behavior of human breast cancer. Int J Cancer 128: 1303-1315.
20. Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, et al. (2003) Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 106: 438-445.
21. Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL, (2005) HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Res 65: 7782-7789.
22. Lokeshwar VB, Cerwinka WH, Lokeshwar BL, (2005) HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Res 65: 2243-2250.
23. Csoka AB, Frost GI, Stern R, (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20: 499-508.
24. Lepperdinger G, Müllegger J, Kreil G, (2001) Hyal2--less active, but more versatile? Matrix Biol 20: 509-514.
25. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, et al. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A 98: 4443-4448.
26. Lokeshwar VB, Selzer MG, (2000) Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells. J Biol Chem 275: 27641-27649.
27. Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, et al. (2004) Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. Int J Cancer 112: 121-129.
28. Wang XY, Tan JX, Vasse M, Delpech B, Ren GS, (2009) Comparison of hyaluronidase expression, invasiveness and tubule formation promotion in ER (-) and ER (+) breast cancer cell lines in vitro. Chin Med J 122: 1300-1304.
29. Tan JX, Ren GS, Tu G, Li XT, Wang XY, et al. (2006) Effect of silencing of hyaluronidase gene HYAL1 by RNA interference on proliferation of human breast cancer cells. Ai Zheng 25: 844-848.
30. West DC, Hampson IN, Arnold F, Kumar S, (1985) Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326.
31. Slevin M, Kumar S, Gaffney J, (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 277: 41046-41059.
32. Liu D, Pearlman E, Diaconu E, Guo K, Mori H, et al. (1996) Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A 93: 7832-7837.
33. Lokeshwar VB, Obek C, Soloway MS, Block NL, (1997) Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 57: 773-777.
34. Jacobson A, Rahmanian M, Rubin K, Heldin P, (2002) Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int J Cancer 102: 212-219.
35. Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, et al. (2008) HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS One 3: e3031.
36. Nykopp TK, Rilla K, Tammi MI, Tammi RH, Sironen R, et al. (2010) Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. BMC Cancer 10: 512.
37. Udabage L, Brownlee GR, Nilsson SK, Brown TJ, (2005) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310: 205-217.
38. Simpson MA, Wilson CM, McCarthy JB, (2002) Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 161: 849-857.
39. Li Y, Li L, Brown TJ, Heldin P, (2007) Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 120: 2557-2567.
40. Enegd B, King JA, Stylli S, Paradiso L, Kaye AH, et al. (2002) Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 50: 1311-1318.
41. Udabage L, Brownlee GR, Stern R, Brown TJ, (2004) Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study. Glycoconj J 20: 461-471.